Sola is the founder and CEO of Hexis Lab, UK. An accomplished complex systems scientist; he was a postdoctoral Research Fellow at Stanford University, School of Engineering, working at NASA AMES California, from 2000 to 2002 and Newcastle University, School of Computing Science from 2002 to 2005. Sola has a track record in entrepreneurial innovation, with many scientific publications to his name as well as ownership of over 10 patents in data analysis, biomedical research and product development. He is one of the founding members of e-Therapeutics plc, a public listed company spun-out of Newcastle University School of Computing Science in 2003. He was technical lead on drug discovery research and development, that resulted in the discovery of 7 repositioned drug candidates documented in different patents. Some of the lead drug candidates are now in advanced oncology clinical trials in the UK and USA.
Mark is a Professor of Molecular Dermatology at the Newcastle University Institute of Cellular Medicine. He has worked as a consultant for many global cosmetic brands. His research focuses on skincare in particular the response of human skin to ultraviolet radiation within the context of skin ageing and cancer. He also has interest in the relationship between oxidative stress, nutritional status and skin ageing as well as the science and use of sunscreens. He has over 100+ peer-reviewed publications many in leading academic journals. He is author of numerous patents, including the invention of a successful product developed as part of a Canadian Newcastle University spin-out company which Mark co-founded in 2003